{"id":"NCT02347657","sponsor":"Vertex Pharmaceuticals Incorporated","briefTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor","officialTitle":"A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01","primaryCompletion":"2017-01-20","completion":"2017-01-20","firstPosted":"2015-01-27","resultsPosted":"2018-06-12","lastUpdate":"2018-06-12"},"enrollment":510,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"VX-661 Plus Ivacaftor Combination","otherNames":[]},{"type":"DRUG","name":"Ivacaftor","otherNames":[]},{"type":"DRUG","name":"VX-661 Plus Ivacaftor Combination Placebo","otherNames":[]},{"type":"DRUG","name":"Ivacaftor placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"VX-661/IVA","type":"EXPERIMENTAL"}],"summary":"This is a Phase 3, randomized, double blind, placebo controlled, parallel group, multicenter study in people with cystic fibrosis (CF) who are homozygous for the F508del CF transmembrane conductance regulator (CFTR) gene mutation.","primaryOutcome":{"measure":"Absolute Change From Baseline (Day 1) in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) Through Week 24","timeFrame":"Day 1, Through Week 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.6,"sd":null},{"arm":"VX-661/IVA","deltaMin":3.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":74,"countries":["United States","Canada","Denmark","France","Germany","Ireland","Italy","Netherlands","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["36509366","29099344"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":47,"n":258},"commonTop":["Cough","Infective pulmonary exacerbation of cystic fibrosis","Nasopharyngitis","Headache","Sputum increased"]}}